With over 20 million Tropis ID injections supplied globally, PharmaJet is making important contributions to the Global Polio ...

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company who has developed and commercialized an intradermal needle-free platform to more effectively administer drugs and biologics, today announced that ...

First self-administered, needle-free injection system approved by Health Canada gives access to safe, painless, cost-effective, and more sustainable drug delivery for chronic illnesses Toronto, ...

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company that has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced that their ...

Toronto, Ontario--(Newsfile Corp. - August 21, 2025) - NuGen Medical Devices Inc. (NGMD:CA) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is pleased to ...

PharmaJet’s Needle-free intradermal (ID) injection device (“Tropis® ID”) will be evaluated as delivery system for the tuberculin skin test (TST) in a clinical study conducted by REDE-TB. The study ...

Toronto, Ontario--(Newsfile Corp. - March 25, 2026) - NuGen Medical Devices Inc. (NGMD:CA) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new patent covering a Ready ...

(A) Dynamics of the electrically induced microbubble, showing the formation, expansion, and shrinking of the microbubble and the shock wave and microjet from the microbubble. (B) Mechanism of the ...

Vaccinating children is always a challenging task, especially when it involves needles, as they can make the process more unpleasant. But when a toddler somewhere in eastern India slept throughout her ...

PharmaJet®, a company focused on improving the performance and outcomes of injectables through needle-free injection technology, announced that its partner, Brazilian Tuberculosis Research Network ...

The MarketWatch News Department was not involved in the creation of this content. -- PharmaJet's Needle-free intradermal (ID) injection device ("Tropis(R) ID") will be evaluated as delivery system for ...